cystic fibrosis gene therapy (SalioGen Therapeutics)

N/A

Report date: 2025/03/20 15:34:09

Base Information

Drug Namecystic fibrosis gene therapy (SalioGen Therapeutics)
Drug Alias NameCFTR gene therapy (SalioGen Therapeutics)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSaliogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSaliogen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A